K., N. et al. 2021. TARGETING NUCLEAR FACTOR KAPPA B WITH CHELATED ZINC COMPOUNDS TOWARDS ANTICANCER DRUG DESIGN. International Journal of Applied Pharmaceutics. 13, 4 (Jul. 2021), 123–127. DOI:https://doi.org/10.22159/ijap.2021v13i4.41650.